Literature DB >> 2830724

The role of chemotherapy in the treatment of bile duct cancer.

R A Oberfield, R L Rossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2830724     DOI： 10.1007/BF01658494

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  25 in total

1.  MALIGNANT OBSTRUCTION OF THE MAJOR HEPATIC DUCTS.

Authors:  J K QUATTLEBAUM; J K QUATTLEBAUM
Journal:  Ann Surg       Date:  1965-06       Impact factor: 12.969

2.  Carcinoma of the extrahepatic bile ducts; review of the literature and report of six cases.

Authors:  K SAKO; G L SEITZINGER; E GARSIDE
Journal:  Surgery       Date:  1957-03       Impact factor: 3.982

3.  Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.

Authors:  D Hohn; J Melnick; R Stagg; D Altman; M Friedman; R Ignoffo; L Ferrell; B Lewis
Journal:  J Clin Oncol       Date:  1985-01       Impact factor: 44.544

4.  Liver dysfunction during protracted hepatic artery infusion of massive doses of fluorinated pyrimidine.

Authors:  A M Khazei; F R Morgenthaler; D D Patel; E Watkins
Journal:  Surg Forum       Date:  1965

5.  Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver.

Authors:  E Watkins; A M Khazei; K S Nahra
Journal:  Surg Gynecol Obstet       Date:  1970-04

Review 6.  Tumors of the extrahepatic biliary radicals.

Authors:  W P Longmire
Journal:  Curr Probl Cancer       Date:  1976-08       Impact factor: 3.187

7.  Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma.

Authors:  G W Smith; R M Bukowski; J S Hewlett; C W Groppe
Journal:  Cancer       Date:  1984-10-15       Impact factor: 6.860

8.  Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer.

Authors:  G Falkson; J M MacIntyre; C G Moertel
Journal:  Cancer       Date:  1984-09-15       Impact factor: 6.860

9.  Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancer.

Authors:  S W Hall; R S Benjamin; W K Murphy; M Valdivieso; G P Bodey
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

10.  Biliary carcinoma. A review of 109 cases.

Authors:  F Alexander; R L Rossi; M O'Bryan; U Khettry; J W Braasch; E Watkins
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565
View more
  9 in total

1.  Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases.

Authors:  J C Flickinger; A H Epstein; S Iwatsuki; B I Carr; T E Starzl
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

2.  Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.

Authors:  Hiroshi Itoh; Koji Nishijima; Yoshiyuki Kurosaka; Shigeru Takegawa; Masato Kiriyama; Shotaro Dohba; Yasuhiko Kojima; Yasuo Saitoh
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

3.  Long-term survival of patients with gallbladder cancer detected during or after laparoscopic cholecystectomy.

Authors:  Tomotaka Akatsu; Masakazu Ueda; Motohide Shimazu; Go Wakabayashi; Koichi Aiura; Minoru Tanabe; Shigeyuki Kawachi; Hiromu Kido; Masaki Kitajima
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

4.  [Surgical, endoscopic or radiologic interventional therapy in bile duct cancer].

Authors:  T Böttger; P Perlia; W Weber; T Junginger
Journal:  Langenbecks Arch Chir       Date:  1990

5.  [Surgical treatment of osseous metastases of the pelvis].

Authors:  S Bading; E Mössinger; S Baus; L Bastian
Journal:  Unfallchirurg       Date:  2004-05       Impact factor: 1.000

6.  Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Authors:  H A Pitt; A Nakeeb; R A Abrams; J Coleman; S Piantadosi; C J Yeo; K D Lillemore; J L Cameron
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

7.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

8.  Resective operations for biliary carcinoma.

Authors:  R L Rossi; M Gagner; F W Heiss; J A Shea
Journal:  Jpn J Surg       Date:  1990-11

9.  Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.

Authors:  C Hsu; Y-C Shen; C-H Yang; K-H Yeh; Y-S Lu; C-H Hsu; H-T Liu; C-C Li; J-S Chen; C-Y Wu; A-L Cheng
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.